These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28214932)

  • 1. Theoretical and experimental study of polycyclic aromatic compounds as β-tubulin inhibitors.
    Olazarán FE; García-Pérez CA; Bandyopadhyay D; Balderas-Rentería I; Reyes-Figueroa AD; Henschke L; Rivera G
    J Mol Model; 2017 Mar; 23(3):85. PubMed ID: 28214932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
    Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
    J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In silico Search for Tubulin Polymerization Inhibitors].
    Sahakyan HK; Arakelov GG; Nazaryan KB
    Mol Biol (Mosk); 2018; 52(4):699-704. PubMed ID: 30113036
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Hadizadeh F; Ghodsi R; Mirzaei S; Sahebkar A
    Comput Math Methods Med; 2022; 2022():4004068. PubMed ID: 35075369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New ligands of the tubulin colchicine site based on X-ray structures.
    Álvarez R; Medarde M; Peláez R
    Curr Top Med Chem; 2014; 14(20):2231-52. PubMed ID: 25434358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
    Coluccia A; Sabbadin D; Brancale A
    Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel antitubulin agents by using a virtual screening approach based on a 7-point pharmacophore model of the tubulin colchi-site.
    Massarotti A; Theeramunkong S; Mesenzani O; Caldarelli A; Genazzani AA; Tron GC
    Chem Biol Drug Des; 2011 Dec; 78(6):913-22. PubMed ID: 22039890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR and 3D-QSAR models in the field of tubulin inhibitors as anticancer agents.
    Marzaro G; Chilin A
    Curr Top Med Chem; 2014; 14(20):2253-62. PubMed ID: 25434357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of small molecule inhibitors that interact with γ-tubulin.
    Friesen DE; Barakat KH; Semenchenko V; Perez-Pineiro R; Fenske BW; Mane J; Wishart DS; Tuszynski JA
    Chem Biol Drug Des; 2012 May; 79(5):639-52. PubMed ID: 22268380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico design of colchicine-based bioisosteric inhibitors of tubulin for the treatment of rheumatoid arthritis.
    Wang L; Yang HJ; Tu R; Shen M; Liu D
    Mol Med Rep; 2017 Oct; 16(4):4823-4828. PubMed ID: 28849128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New indole-based chalconoids as tubulin-targeting antiproliferative agents.
    Mirzaei H; Shokrzadeh M; Modanloo M; Ziar A; Riazi GH; Emami S
    Bioorg Chem; 2017 Dec; 75():86-98. PubMed ID: 28922629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
    Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
    Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into the design of indole derivatives as tubulin polymerization inhibitors.
    Li Y; Yang J; Niu L; Hu D; Li H; Chen L; Yu Y; Chen Q
    FEBS Lett; 2020 Jan; 594(1):199-204. PubMed ID: 31369682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of N-phenyl-N'-(2-chloroethyl)ureas in the colchicine-binding site at the interface between alpha- and beta-tubulin.
    Fortin S; Wei L; Moreau E; Labrie P; Petitclerc E; Kotra LP; C-Gaudreault R
    Bioorg Med Chem; 2009 May; 17(10):3690-7. PubMed ID: 19398206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Computational Analysis of Indomethacin Derivative as Tubulin Inhibitor: Insights into Development of Chemotherapeutic Agents.
    Costa KM; Alves CN; Silva JR; Lameira J
    Comb Chem High Throughput Screen; 2016; 19(6):431-6. PubMed ID: 27141989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery.
    Wang Y; Zhang H; Gigant B; Yu Y; Wu Y; Chen X; Lai Q; Yang Z; Chen Q; Yang J
    FEBS J; 2016 Jan; 283(1):102-11. PubMed ID: 26462166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach.
    Nguyen TL; McGrath C; Hermone AR; Burnett JC; Zaharevitz DW; Day BW; Wipf P; Hamel E; Gussio R
    J Med Chem; 2005 Sep; 48(19):6107-16. PubMed ID: 16162011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study based on docking and molecular dynamics simulations over HDAC-tubulin dual inhibitors.
    Hassanzadeh M; Bagherzadeh K; Amanlou M
    J Mol Graph Model; 2016 Nov; 70():170-180. PubMed ID: 27750186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of new chromene-based inhibitors of tubulin using structure-based virtual screening and molecular dynamics simulation methods.
    Aryapour H; Dehdab M; Sohraby F; Bargahi A
    Comput Biol Chem; 2017 Dec; 71():89-97. PubMed ID: 28992456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors.
    Yin Y; Qiao F; Jiang LY; Wang SF; Sha S; Wu X; Lv PC; Zhu HL
    Bioorg Med Chem; 2014 Aug; 22(15):4285-92. PubMed ID: 24916028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.